Abstract
The in vitro evaluation of a series of (hetero)aromatic-substituted 4-hydroxycyclohexa-2,5-dienones (quinols) and analogues against M. tuberculosis is reported. The most active compound in the series was found to be 4-(benzothiazol-2-yl)-4-hydroxycyclohexa-2,5-dienone 1a with a minimum inhibitory concentration of 0.78 μg/mL. Biochemical evidence for involvement of the small redox protein thioredoxin C - a novel drug target - is also presented.
Keywords: Antitubercular activity, Mycobacterium tuberculosis (MTb), quinols, thioredoxin
Letters in Drug Design & Discovery
Title: Antitubercular Properties of Substituted Hydroxycyclohexadienones
Volume: 3 Issue: 6
Author(s): Manish Shah, Geoffrey Wells, Tracey D. Bradshaw, Charles A. Laughton, Malcolm F.G. Stevens and Andrew D. Westwell
Affiliation:
Keywords: Antitubercular activity, Mycobacterium tuberculosis (MTb), quinols, thioredoxin
Abstract: The in vitro evaluation of a series of (hetero)aromatic-substituted 4-hydroxycyclohexa-2,5-dienones (quinols) and analogues against M. tuberculosis is reported. The most active compound in the series was found to be 4-(benzothiazol-2-yl)-4-hydroxycyclohexa-2,5-dienone 1a with a minimum inhibitory concentration of 0.78 μg/mL. Biochemical evidence for involvement of the small redox protein thioredoxin C - a novel drug target - is also presented.
Export Options
About this article
Cite this article as:
Shah Manish, Wells Geoffrey, Bradshaw D. Tracey, Laughton A. Charles, Stevens F.G. Malcolm and Westwell D. Andrew, Antitubercular Properties of Substituted Hydroxycyclohexadienones, Letters in Drug Design & Discovery 2006; 3 (6) . https://dx.doi.org/10.2174/157018006777805486
DOI https://dx.doi.org/10.2174/157018006777805486 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox
Nanoscience & Nanotechnology-Asia Scanning the Genome of Mycobacterium tuberculosis to Identify Potential Lectins
Protein & Peptide Letters The Application of High Throughput siRNA Screening Technology to Study Host-Pathogen Interactions
Combinatorial Chemistry & High Throughput Screening HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews Evaluation of Risk Factors for Development of Anti-Tubercular Therapy Induced Hepatotoxicity: A Prospective Study
Current Drug Safety Drug-Induced Hypokalaemia
Current Drug Safety Nanoemulsion-Based Transdermal Drug Delivery System for the Treatment of Tuberculosis
Recent Patents on Anti-Infective Drug Discovery Recent Developments in Synthetic Oligosaccharide-Based Bacterial Vaccines
Current Topics in Medicinal Chemistry Molecular Dynamics Simulations of Protein Targets Identified in Mycobacterium tuberculosis
Current Medicinal Chemistry Single Amino Acid Repeats Connect Viruses to Neurodegeneration
Current Drug Discovery Technologies Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
Current Pharmaceutical Design Review of the Biological Activity of Maslinic Acid
Current Drug Targets A Comprehensive Review on Recent advances in Synthesis & Pharmacotherapeutic potential of Benzothiazoles
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Immunocompromised Host: Immune Alterations in Splenectomized Patients and Clinical Implications
Current Pharmaceutical Design Computer Aided Drug Design: Success and Limitations
Current Pharmaceutical Design Microwave-assisted Single Step Cinnamic Acid Derivatization and Evaluation for Cytotoxic Potential
Current Pharmaceutical Biotechnology Dysregulation of RNA Mediated Gene Expression in Motor Neuron Diseases
CNS & Neurological Disorders - Drug Targets Combination Therapy as a Strategy to Control Infections Caused by Multi-resistant Bacteria: Current Review
Current Drug Targets A Brief Survey on Computational Approaches to Reveal Drug and Disease Associations
Current Drug Discovery Technologies Allergic Aspergillosis and the Antigens of Aspergillus fumigatus
Current Protein & Peptide Science